DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine

Frontiers in Microbiology

Volumn 6, Issue JUL, 2015, Pages

  Roy, Upal ^a   Atluri, Venkata S R ^a   Agudelo, Marisela ^a   Yndart, Adriana ^a   Huang, Zaohua ^a   Nair, Madhavan ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Cocaine; DJ1; HIV 1; HIV associated neurological disorder; Parkinson's disease; SK N MC

Indexed keywords

COCAINE; DJ 1 PROTEIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; NEUROBLASTOMA; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VIRUS REPLICATION; WESTERN BLOTTING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84938849315     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00749     Document Type: Article

References (43)

1. Agudelo, M., Gandhi, N., Saiyed, Z., Pichili, V., Thangavel, S., Khatavkar, P., et al. (2011). Effects of alcohol on histone deacetylase 2 (HDAC2) and the neuroprotective role of Trichostatin A (TSA). Alcohol. Clin. Exp. Res. 35, 1550-1556. doi: 10.1111/j.1530-0277.2011.01492.x
2. Aksenov, M. Y., Aksenova, M. V., Nath, A., Ray, P. D., Mactutus, C. F., and Booze, R. M. (2006). Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Neurotoxicology 27, 217-228. doi: 10.1016/j.neuro.2005.10.003
3. Alvarez Losada, S., Canto-Nogues, C., and Munoz-Fernandez, M. A. (2002). A new possible mechanism of human immunodeficiency virus type 1 infection of neural cells. Neurobiol. Dis. 11, 469-478. doi: 10.1006/nbdi.2002.0566
4. Atluri, V. S., Kanthikeel, S. P., Reddy, P. V., Yndart, A., and Nair, M. P. (2013). Human synaptic plasticity gene expression profile and dendritic spine density changes in HIV-infected human CNS cells: role in HIV-associated neurocognitive disorders (HAND). PLoS ONE 8:e61399. doi: 10.1371/journal.pone.0061399
5. Atluri, V. S. R., Pilakka-Kanthikeel, S., Samikkannu, T., Sagar, V., Kurapati, K. R. V., Saxena, S. K., et al. (2014). Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder. Mol. Brain 7, 37-37. doi: 10.1186/1756-6606-7-37
6. Best, B. M., Letendre, S. L., Brigid, E., Clifford, D. B., Collier, A. C., Gelman, B. B., et al. (2009). Low atazanavir concentrations in cerebrospinal fluid. AIDS 23, 83-87. doi: 10.1097/QAD.0b013e328317a702
7. Blesa, J., and Przedborski, S. (2014). Parkinson's disease: animal models and dopaminergic cell vulnerability. Front. Neuroanat. 8:155. doi: 10.3389/fnana.2014.00155
8. Brew, B., Crowe, S. M., Landay, A., Cysique, L., and Guillemin, G. (2009). Neurodegeneration and ageing in the HAART era. J. Neuroimmune Pharmacol. 4, 163-174. doi: 10.1007/s11481-008-9143-1
9. Capone, C., Cervelli, M., Angelucci, E., Colasanti, M., Macone, A., Mariottini, P., et al. (2013). A role for spermine oxidase as a mediator of reactive oxygen species production in HIV-Tat-induced neuronal toxicity. Free Radic. Biol. Med. 63, 99-107. doi: 10.1016/j.freeradbiomed.2013.05.007
10. Cysique, L. A., Maruff, P., and Brew, B. J. (2006). Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology 66, 1447-1450. doi: 10.1212/01.wnl.0000210477.63851.d3
11. Dalvi, P., Wang, K., Mermis, J., Zeng, R., Sanderson, M., Johnson, S., et al. (2014). HIV-1/cocaine induced oxidative stress disrupts tight junction protein-1 in human pulmonary microvascular endothelial cells: role of Ras/ERK1/2 pathway. PLoS ONE 9:e85246. doi: 10.1371/journal.pone.0085246
12. Devlin, K. N., Gongvatana, A., Clark, U. S., Chasman, J. D., Westbrook, M. L., Tashima, K. T., et al. (2012). Neurocognitive effects of HIV, hepatitis C, and substance use history. J. Int. Neuropsychol. Soc. 18, 68-78. doi: 10.1017/s1355617711001408
13. Eugenin, E. A., and Berman, J. W. (2007). Gap junctions mediate human immunodeficiency virus-bystander killing in astrocytes. J. Neurosci. 27, 12844-12850. doi: 10.1523/JNEUROSCI.4154-07.2007
14. Everall, I., Vaida, F., Khanlou, N., Lazzaretto, D., Achim, C., Letendre, S., et al. (2009). Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J. Neurovirol. 15, 360-370. doi: 10.3109/13550280903131915
15. Gago, M. F., Rosas, M. J., Linhares, P., Massano, J. O., Sarmento, A. N., and Vaz, R. (2011). Deep brain stimulation of the subthalamic nucleus for Parkinson's disease in a patient with HIV infection: dual clinical benefit. Case Rep. Neurol. 3, 219-222. doi: 10.1159/000332610
16. Gandhi, N., Saiyed, Z., Napuri, J., Samikkannu, T., Reddy, P. B., Agudelo, M., et al. (2010). Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder. J. Neurovirol. 16, 294-305. doi: 10.3109/13550284.2010.499891
17. Grant, I. (2008). Neurocognitive disturbances in HIV. Int. Rev. Psychiatry 20, 33-47. doi: 10.1080/09540260701877894
18. Hargus, N. J., and Thayer, S. A. (2013). Human immunodeficiency virus-1 Tat protein increases the number of inhibitory synapses between hippocampal neurons in culture. J. Neurosci. 33, 17908-17920. doi: 10.1523/jneurosci.1312-13.2013
19. Harouse, J. M., Collman, R. G., and González-Scarano, F. (1995). Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell line. J. Virol. 69, 7383-7390
20. Hering, R., Strauss, K. M., Tao, X., Bauer, A., Woitalla, D., Mietz, E.-M., et al. (2004). Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7). Hum. Mutat. 24, 321-329. doi: 10.1002/humu.20089
21. Hinkin, C. H., Castellon, S. A., Levine, A. J., Barclay, T. R., and Singer, E. J. (2008). Neurocognition in individuals co-infected with HIV and hepatitis C. J. Addict. Dis. 27, 11-17. doi: 10.1300/J069v27n02_02
22. Kanmogne, G. D., Singh, S., Roy, U., Liu, X., Mcmillan, J., Gorantla, S., et al. (2012). Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells. Int. J. Nanomedicine 7, 2373-2388. doi: 10.2147/ijn.s29454
23. Kurapati, K. R., Atluri, V. S., Samikkannu, T., and Nair, M. P. (2013). Ashwagandha (Withania somnifera) reverses beta-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). PLoS ONE 8:e77624. doi: 10.1371/journal.pone.0077624
24. Kusao, I., Shiramizu, B., Liang, C. Y., Grove, J., Agsalda, M., Troelstrup, D., et al. (2012). Cognitive performance related to HIV-1-infected monocytes. J. Neuropsychiatry Clin. Neurosci. 24, 71-80. doi: 10.1176/appi.neuropsych.11050109
25. Liang, C.-L., Wang, T. T., Luby-Phelps, K., and German, D. C. (2007). Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease. Exp. Neurol. 203, 370-380. doi: 10.1016/j.expneurol.2006.08.015
26. Lopert, P., and Patel, M. (2014). Brain mitochondria from DJ-1 knockout mice show increased respiration-dependent hydrogen peroxide consumption. Redox Biol. 2, 667-672. doi: 10.1016/j.redox.2014.04.010
27. Meade, C. S., Towe, S. L., Skalski, L. M., and Robertson, K. R. (2015). Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States. Drug Alcohol Depend. 149, 128-135. doi: 10.1016/j.drugalcdep.2015.01.034
28. Nair, M. P. N., Mahajan, S. D., Schwartz, S. A., Reynolds, J., Whitney, R., Bernstein, Z., et al. (2005). Cocaine modulates dendritic cell-specific C type intercellular adhesion molecule-3-grabbing nonintegrin expression by dendritic cells in HIV-1 patients. J. Immunol. 174, 6617-6626. doi: 10.4049/jimmunol.174.11.6617
29. Ohagen, A., Ghosh, S., He, J., Huang, K., Chen, Y., Yuan, M., et al. (1999). Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope. J. Virol. 73, 897-906.
30. Payton, A. (2006). Investigating cognitive genetics and its implications for the treatment of cognitive deficit. Genes Brain Behav. 5, 44-53. doi: 10.1111/j.1601-183X.2006.00194.x
31. Price, R. W. (1996). Neurological complications of HIV infection. Lancet 348, 445-452. doi: 10.1016/S0140-6736(95)11035-6
32. Requejo-Aguilar, R., Lopez-Fabuel, I., Jimenez-Blasco, D., Fernandez, E., Almeida, A., and Bolanos, J. P. (2015). DJ1 represses glycolysis and cell proliferation by transcriptionally up-regulating pink1. Biochem. J. 467, 303-310. doi: 10.1042/BJ20141025
33. Robinson-Papp, J., Byrd, D., Mindt, M. R., Oden, N. L., Simpson, D. M., Morgello, S., et al. (2008). Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort. Arch. Neurol. 65, 1096-1101. doi: 10.1001/archneur.65.8.1096
34. Roy, U., Bulot, C., Honer Zu Bentrup, K., and Mondal, D. (2013). Specific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavir. PLoS ONE 8:e75374. doi: 10.1371/journal.pone.0075374
35. Schapira, A. H. V. (2009). Etiology and pathogenesis of Parkinson disease. Neurol. Clin. 27, 583-603. doi: 10.1016/j.ncl.2009.04.004
36. Schulte, C., and Gasser, T. (2011). Genetic basis of Parkinson's disease: inheritance, penetrance, and expression. Appl. Clin. Genet. 4, 67-80. doi: 10.2147/tacg.s11639
37. Sun, Y., Zhang, W.-J., Zhao, X., Yuan, R.-P., Jiang, H., and Pu, X.-P. (2014). PARK7 protein translocating into spermatozoa mitochondria in Chinese asthenozoospermia. Reproduction 148, 249-257. doi: 10.1530/rep-14-0222
38. Tallarida, R. J. (2011). Quantitative methods for assessing drug synergism. Genes Cancer 2, 1003-1008. doi: 10.1177/1947601912440575
39. Tisch, S., and Brew, B. (2009). Parkinsonism in hiv-infected patients on highly active antiretroviral therapy. Neurology 73, 401-403. doi: 10.1212/WNL.0b013e3181b04b0d
40. Varatharajan, L., and Thomas, S. A. (2009). The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research. Antivir. Res. 82, A99-A109. doi: 10.1016/j.antiviral.2008.12.013
41. Vasseur, S., Afzal, S., Tardivel-Lacombe, J. L., Park, D. S., Iovanna, J. L., and Mak, T. W. (2009). DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses. Proc. Natl. Acad. Sci. U.S.A. 106, 1111-1116. doi: 10.1073/pnas.0812745106
42. Wang, D., Melancon, J. K., Verbesey, J., Hu, H., Liu, C., Aslam, S., et al. (2013). Microvascular endothelial dysfunction and enhanced thromboxane and endothelial contractility in patients with HIV. J. AIDS Clin. Res. 4, 267. doi: 10.4172/2155-6113.1000267
43. Wilhelmus, M. M. M., Nijland, P. G., Drukarch, B., De Vries, H. E., and Van Horssen, J. (2012). Involvement and interplay of Parkin, PINK1, and DJ1 in neurodegenerative and neuroinflammatory disorders. Free Radic. Biol. Med. 53, 983-992. doi: 10.1016/j.freeradbiomed.2012.05.040